FANELLI, GIUSEPPE NICOLO'
 Distribuzione geografica
Continente #
NA - Nord America 3.351
AS - Asia 1.836
EU - Europa 1.361
SA - Sud America 349
Continente sconosciuto - Info sul continente non disponibili 131
AF - Africa 119
OC - Oceania 4
Totale 7.151
Nazione #
US - Stati Uniti d'America 3.206
SG - Singapore 702
IT - Italia 655
CN - Cina 367
HK - Hong Kong 328
BR - Brasile 280
DE - Germania 146
VN - Vietnam 145
SE - Svezia 129
CA - Canada 97
GB - Regno Unito 92
FR - Francia 62
IN - India 53
FI - Finlandia 48
NL - Olanda 47
BD - Bangladesh 45
CI - Costa d'Avorio 44
JP - Giappone 41
AT - Austria 38
RU - Federazione Russa 36
AR - Argentina 25
PL - Polonia 25
MX - Messico 21
TR - Turchia 21
PK - Pakistan 17
ZA - Sudafrica 17
BG - Bulgaria 16
KR - Corea 16
IQ - Iraq 15
SA - Arabia Saudita 15
EC - Ecuador 14
MA - Marocco 14
VE - Venezuela 13
ID - Indonesia 12
CH - Svizzera 9
SN - Senegal 9
ES - Italia 8
NG - Nigeria 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
CR - Costa Rica 7
RO - Romania 7
JM - Giamaica 6
KE - Kenya 6
LT - Lituania 6
MY - Malesia 6
TW - Taiwan 6
UZ - Uzbekistan 6
CO - Colombia 5
EG - Egitto 5
UA - Ucraina 5
AL - Albania 4
AU - Australia 4
DZ - Algeria 4
GR - Grecia 4
IE - Irlanda 4
KZ - Kazakistan 4
PH - Filippine 4
PY - Paraguay 4
AO - Angola 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
IR - Iran 3
NP - Nepal 3
PS - Palestinian Territory 3
PT - Portogallo 3
TN - Tunisia 3
UY - Uruguay 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BE - Belgio 2
BZ - Belize 2
CL - Cile 2
DK - Danimarca 2
HN - Honduras 2
JO - Giordania 2
LB - Libano 2
MK - Macedonia 2
PE - Perù 2
TH - Thailandia 2
BO - Bolivia 1
BS - Bahamas 1
CM - Camerun 1
CY - Cipro 1
ET - Etiopia 1
GQ - Guinea Equatoriale 1
GT - Guatemala 1
IL - Israele 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
ML - Mali 1
MW - Malawi 1
PR - Porto Rico 1
RS - Serbia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.020
Città #
San Jose 538
Singapore 410
Ashburn 377
Hong Kong 321
Dallas 249
Santa Clara 239
Shanghai 116
Pisa 107
Los Angeles 103
New York 85
Council Bluffs 82
Chandler 76
Munich 70
Milan 65
Boardman 63
Toronto 60
Beijing 55
Florence 48
Ho Chi Minh City 46
Abidjan 44
London 39
Rome 39
Hanoi 36
Frankfurt am Main 34
Tokyo 34
Buffalo 32
Princeton 30
Lauterbourg 29
Lawrence 29
São Paulo 27
Vienna 27
Fairfield 26
Hefei 24
Turku 23
Amsterdam 21
Chicago 20
Medford 19
Redondo Beach 18
Chennai 17
Denver 17
Houston 17
Atlanta 16
Orem 16
Sofia 16
Warsaw 16
Helsinki 15
Montreal 15
San Francisco 15
Lucca 14
Seoul 13
Baltimore 12
Genoa 12
Rio de Janeiro 12
Wilmington 12
Cascina 11
Riyadh 11
Bari 10
Haiphong 10
Vicopisano 10
Baghdad 9
Dakar 9
Johannesburg 9
Lappeenranta 9
Nuremberg 9
Ogden 9
Phoenix 9
Quanzhou 9
Brescia 8
City of London 8
Dhaka 8
Istanbul 8
Poplar 8
Seattle 8
Baku 7
Fuzhou 7
Lagos 7
San Diego 7
Woodbridge 7
Indianapolis 6
Nairobi 6
Naples 6
New Delhi 6
Palm Bay 6
Piscataway 6
Quito 6
Salvador 6
San José 6
Tashkent 6
Barletta 5
Brasília 5
Bremen 5
Cambridge 5
Casablanca 5
Da Nang 5
Düsseldorf 5
Hải Dương 5
Karachi 5
Mexico City 5
Monte Argentario 5
Nottingham 5
Totale 4.223
Nome #
Macrophage Polarization and Prognostic Implications in Glioblastoma 335
CD80/CD163 macrophage signature identifies high-risk glioblastoma patients 308
Correction to: Association of XRCC3 rs1799794 polymorphism with survival of glioblastoma multiforme patients treated with combined radio-chemotherapy 270
Association of XRCC3 rs1799794 polymorphism with survival of glioblastoma multiforme patients treated with combined radio-chemotherapy 259
Circulating Cell-Free DNA in Renal Cell Carcinoma: The New Era of Precision Medicine 227
Heterogeneity of Hormone Receptors and HER2 in Breast Cancer Cutaneous Metastases: An Institutional Experience 220
Old and New Systemic Immune-Inflammation Indexes Are Associated with Overall Survival of Glioblastoma Patients Treated with Radio-Chemotherapy 182
Tumour stroma characterization for the clinical stratification of HR+/HER2- breast cancer 179
Cervical Adenocarcinoma: A Still Under-investigated Malignancy 159
Decipher the glioblastoma microenvironment: The first milestone for new groundbreaking therapeutic strategies 154
The Prognostic Impact of Gender, Therapeutic Strategies, Molecular Background, and Tumor-Infiltrating Lymphocytes in Glioblastoma: A Still Unsolved Jigsaw 151
Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide survey 142
Is it time to consider the Androgen receptor as a therapeutic target in breast cancer? 141
Immunohistochemistry for thymidine kinase-1 (Tk1): A potential tool for the prognostic stratification of breast cancer patients 140
Surgical outcome and molecular pattern characterization of recurrent glioblastoma multiforme: A single-center retrospective series 134
Epstein-Barr virus associated gastric dysplasia: a new rare entity? 131
New insights in the expression of stromal caveolin 1 in breast cancer spread to axillary lymph nodes 124
Deciphering the Tumor Microenvironment in Prostate Cancer: A Focus on the Stromal Component 124
Cervical Adenocarcinoma: A Still Under-investigated Malignancy 121
Stem cells for treatment of cardiovascular diseases: An umbrella review of randomized controlled trials 110
Insights from Multigene Panel Sequencing and Comparative Analysis of Metaplastic Carcinoma of the Breast 109
The heterogeneous clinical and pathological landscapes of metastatic Braf-mutated colorectal cancer 107
Distinct mesenchymal cell states mediate prostate cancer progression 106
Fibrin associated large B-cell lymphoma accidentally identified in a breast implant capsule: a molecular report of a rare entity 105
Recent Advances in Cancer Plasticity: Cellular Mechanisms, Surveillance Strategies, and Therapeutic Optimization 104
Follicular melanoma—A rare entity: First description of an association with a nevus 103
Shedding light on PRAME expression in dysplastic nevi: a cohort study 102
Epidemiology of Merkel cell carcinoma in Tuscany (Italy), 2006-2021 96
Metabolomics of prostate cancer gleason score in tumor tissue and serum 93
Value of Artificial Intelligence in Evaluating Lymph Node Metastases 92
Prostate stromal transcriptome as biomarker of aggressive prostate cancer 92
Intestinal metaplasia of the urinary tract harbors potentially oncogenic genetic variants 89
Pyruvate Kinase M1 Suppresses Development and Progression of Prostate Adenocarcinoma 85
Genetic, epigenetic, and immunologic profiling of MMR-deficient relapsed glioblastoma 82
LONG-NONCODING RNAs in gastroesophageal cancers 82
Molecularly defined tumour microenvironment ecosystems enhance prognostic stratification in low- and intermediate-risk prostate cancer 82
Assessment of estrogen receptor low positive status in breast cancer: Implications for pathologists and oncologists 78
Noncoding RNAs as drivers of the phenotypic plasticity of oesophageal mucosa 77
Pre-Implantation Kidney Biopsies in Extended Criteria Donors: From On Call to Expert Pathologist, from Conventional Microscope to Digital Pathology 76
Cerebral Lymphoproliferation in a Patient with Kabuki Syndrome 76
Correction to: Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases (Cancer Cell International (2018) 18 (131) DOI: 10.1186/s12935-018-0634-8) 76
Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases 75
Blocking lipid synthesis induces DNA damage in prostate cancer and increases cell death caused by PARP inhibition 74
Is it TIME for the clinical stratification of HR+/HER2- breast cancer? 72
Thyroid-like follicular carcinoma of the kidney: The mutational profiling reveals a BRAF wild type status 72
Cell-Free DNA: Unveiling the Future of Cancer Diagnostics and Monitoring 71
Antibody-Based Multiplex Image Analysis: Standard Analytical Workflows and Artificial Intelligence Tools for Pathologists 71
A Metastatic Squamous Cell Carcinoma in a Diabetic Foot: Case Report 69
MiR-21 up-regulation in ampullary adenocarcinoma and its pre-invasive lesions 68
Deciphering Complexity: The Molecular Landscape of Castration-Resistant Prostate Cancer 67
PD-L1 overexpression in ampulla of Vater carcinoma and its pre-invasive lesions 66
Ovarian teratoma or uterine malformation? PET/MRI as a novel useful tool in NMDAR encephalitis 66
Pathological Tumor Regression Grade Classifications in Gastrointestinal Cancers: Role on Patients’ Prognosis 64
Calcific myonecrosis of the leg: A rare entity 64
Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled cases 62
Rosai-Dorfman Disease: Case Report of an Unusual Testicular Involvement and Review of Literature 61
Liquid biopsy in breast cancer: Redefining precision medicine 56
Methylation reprogramming associated with aggressive prostate cancer and ancestral disparities 56
Mesenchymal cell populations associated with different stages of prostate cancer progression in mice and human 55
Spatially organized lymphocytic microenvironments in high grade primary prostate tumors 51
The prostate stromal transcriptome in aggressive and lethal prostate cancer 49
Standard Operating Procedures (SOPs) for non-invasive multiple biomarkers detection in an academic setting: A critical review of the literature for the RENOVATE study protocol 49
Targeting cancer metabolism: Therapeutic potential of the fatty acid synthase (FASN) inhibitors 49
Notch-based gene signature for predicting the response to neoadjuvant chemotherapy in triple-negative breast cancer 49
ELOVL5 affects prostate cancer cell proliferation and modulates the AR pathway 46
Pathogenic variants reveal candidate genes for prostate cancer germline testing for men of African ancestry 38
The role of TMPRSS2_ERG fusions in modulating tumor microenvironment in prostate cancer 37
Deciphering the stromal molecular landscape: the correlation between p16 and α-SMA in epithelial ovarian cancer 24
Mapping prostate cancer pathobiology: A review of genetically engineered mouse models (GEMMs) 22
Lipidomic profiling in metastatic prostate cancer captures tumor metabolic rewiring and its modulation by androgen receptor–targeting therapy 8
TFE3-rearranged and TFEB-altered renal cell carcinoma: from classification to real life. Insights from a national Italian survey 6
The role of pathology in immunotherapy and targeted therapy for renal cell carcinoma 6
Diagnostic practice and awareness of SDH- and FH-deficient renal cell carcinoma: results from an Italian Study Group of uropathology (GIUP) survey 5
Totale 7.151
Categoria #
all - tutte 21.838
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.838


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022199 0 0 6 1 17 19 6 6 10 50 27 57
2022/2023375 41 52 48 14 25 44 3 23 82 1 38 4
2023/2024375 13 24 43 72 39 46 27 8 3 19 32 49
2024/20252.109 74 65 29 122 158 266 151 91 201 221 236 495
2025/20263.054 182 216 341 316 310 196 431 176 206 468 117 95
2026/2027958 175 628 155 0 0 0 0 0 0 0 0 0
Totale 7.151